IRIS
MASSA, FEDERICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.288
AS - Asia 493
SA - Sud America 62
NA - Nord America 61
AF - Africa 9
Totale 6.913
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.272
SG - Singapore 199
VN - Vietnam 129
CN - Cina 122
US - Stati Uniti d'America 49
BR - Brasile 42
HK - Hong Kong 19
MX - Messico 9
AR - Argentina 8
ID - Indonesia 8
PK - Pakistan 4
UA - Ucraina 4
CL - Cile 3
EC - Ecuador 3
CA - Canada 2
CO - Colombia 2
ES - Italia 2
IQ - Iraq 2
MA - Marocco 2
RU - Federazione Russa 2
VE - Venezuela 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BE - Belgio 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DZ - Algeria 1
FI - Finlandia 1
IE - Irlanda 1
IL - Israele 1
IN - India 1
KE - Kenya 1
KW - Kuwait 1
PH - Filippine 1
PL - Polonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SE - Svezia 1
SV - El Salvador 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 6.913
Salva come PNG Salva come JPEG
Città #
Genoa 3.367
Genova 1.533
Vado Ligure 817
Rapallo 474
Ho Chi Minh City 56
Singapore 41
Beijing 36
Ashburn 35
Bordighera 29
Hanoi 27
Hong Kong 18
Milan 6
Pisa 6
Mexico City 5
Savona 5
Haiphong 4
Hải Dương 4
Rome 4
Biên Hòa 3
Jakarta 3
Naples 3
Ninh Bình 3
Phủ Lý 3
São Paulo 3
Alessandria 2
Atlanta 2
Bari 2
Bắc Ninh 2
Cotia 2
Hortolândia 2
Johannesburg 2
Lahore 2
Lviv 2
Montreal 2
Porto Alegre 2
Quito 2
Seveso 2
São José dos Pinhais 2
Thái Bình 2
Tianjin 2
Abidjan 1
Ahome 1
Algiers 1
Altamira 1
Alvorada 1
Avellaneda 1
Baghdad 1
Baku 1
Barreiros 1
Belgrade 1
Belo Horizonte 1
Blumenau 1
Bogotá 1
Buon Ma Thuot 1
Caieiras 1
Cao Lanh 1
Caracas 1
Carpiano 1
Casablanca 1
Caxias do Sul 1
Chalatenango 1
Changsha 1
Chernihiv 1
Cidade Ocidental 1
Cluj-Napoca 1
Curitiba 1
Da Nang 1
Dallas 1
Dar es Salaam 1
Denpasar 1
Denver 1
Dhaka 1
Dubai 1
Dublin 1
El Bosque 1
Faisalabad 1
Fazenda Rio Grande 1
Feira de Santana 1
Franca 1
Ghent 1
Guadalajara 1
Gualeguaychú 1
Guayaquil 1
Ha Long 1
Hamad Town 1
Harare 1
Honolulu 1
Huauchinango 1
Hưng Yên 1
Jaboatão dos Guararapes 1
Jandira 1
Jaú 1
Juiz de Fora 1
Karachi 1
Korosten 1
Krasnyy Kut 1
Kuwait City 1
Lancaster 1
Lappeenranta 1
Los Angeles 1
Totale 6.577
Salva come PNG Salva come JPEG
Nome #
Spinocerebellar ataxia 17: full phenotype in a 41 CAG/CAA repeats carrier. 171
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 160
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 159
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 158
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 150
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 147
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 141
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD) Rik Ossenkoppele 137
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 135
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 133
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 128
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 128
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 120
Getting the high school diploma with only one hemisphere: a case report 120
Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia 119
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 118
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 114
Limbic Network Derangement Mediates Unawareness of Apathy in Mild Cognitive Impairment due to Alzheimer’s Disease: Clues from [18F]FDG PET Voxel-Wise Analysis 113
Bendamustine-rituximab (BR) combined therapy for treatment of immuno-mediated neuropathies associated with hematologic malignancy. 111
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 111
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 109
A case series of parainfectious Guillain-Barré syndrome linked to influenza A (H1N1) virus infection 108
Neuroimaging Findings in Mild Cognitive Impairment 107
Utility of quantitative EEG in early Lewy body disease 105
Brain metabolic correlates of persistent olfactory dysfunction after sars-cov2 infection 103
Increased incidence of axonal Guillain-Barré syndrome in La Spezia area of Italy: A 13-year follow-up study 101
Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study 96
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 92
Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS 92
Clinical utility and research frontiers of neuroimaging in movement disorders 91
N-methyl-D-aspartate receptor antibody-related pathologies and pre-existent mental state disorders 89
FDG-PET and ASL MRI identify largely overlapping hypermetabolic and hyperperfusion changes in limbic autoimmune encephalitis 88
Subgroup comparison according to clinical phenotype and serostatus in autoimmune encephalitis: a multicenter retrospective study 88
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 87
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 87
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 86
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 84
FDG PET Unveils the Course of Paraneoplastic Cerebellar Degeneration: A Semiquantitative Analysis 83
Clinical and biological underpinnings of longitudinal atrophy pattern progression in Alzheimer's disease 82
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 80
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 79
WHAT MAINTENANCE THERAPY TO PERFORM IN PATIENTS WITH ANTI-MAG NEUROPATHY AFTER THE FIRST CYCLE OF RITUXIMAB? A COMPARISON BETWEEN TWO REGIMENS 78
Sex differences in neuroimaging biomarkers in healthy subjects and dementia 77
Abnormal sweating and “skin flushing” as possible predictive factor for treatment related fluctuations in Guillain-Barré syndrome: a case series and a review of the literature 77
Neurological long-COVID in the outpatient clinic: Two subtypes, two courses 77
A case of Huntington disease-like 2 in a patient of African ancestry: the everlasting support of clinical examination in the molecular era 75
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 75
How can we define a brain health chart? A narrative review and a proposal 72
Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB) 70
Alzheimer's disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era 66
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 66
Metabolic and dopaminergic correlates of intellectual enrichment in de-novo Parkinson's disease patients 66
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 65
Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years 65
Incident anti-LGI1 autoimmune encephalitis during dementia with Lewy bodies: when Occam razor is a double-edged sword 63
Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset 63
Compressed sensing (CS) MP2RAGE versus standard MPRAGE: A comparison of derived brain volume measurements 61
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies 59
Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy 58
The Role of Monoaminergic Tones and Brain Metabolism in Cognition in~de~novo Parkinson's Disease 56
COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome 56
Anti-LGI1 encephalitis and Langerhans cell histiocytosis: two associated entities? A case report 55
18F-FDG-PET/CT (FDG-PET) in Neurodegenerative Disease 54
Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data 52
Machine learning based analysis of FDG-PET image data for the diagnosis of neurodegenerative diseases 50
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 49
Autoimmune encephalitis: what the radiologist needs to know 46
Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes 46
Toward Quantitative Neurology: Sensors to Assess Motor Deficits in Dementia 46
Integrating cerebrospinal fluid and [18F]-fluorodeoxyglucose positron emission tomography to diagnose Alzheimer's disease and research its pathophysiological substrates 46
Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments 45
Presynaptic Dopaminergic Imaging Characterizes Patients with REM Sleep Behavior Disorder Due to Synucleinopathy 45
Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort 44
Case 4: Parkinson’s Disease with Onset as Mild Cognitive Impairment (MCI) 43
null 41
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers 37
Ma2 antibody-associated limbic encephalitis: The early etiology treatment may modify the disease clinical trajectory 37
[18F]FDG PET metabolic correlates of cerebrospinal fluid TAR DNA-binding protein 43 in prodromal Alzheimer's disease 35
Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease 34
Investigating interleukin-8 in Alzheimer's disease: A comprehensive review 32
Editorial: CSF and blood biomarkers in COVID-19 and other neuroinfectious diseases 28
Clinical versus biomarker-based diagnosis of neurocognitive disorders – Authors' reply 28
Abnormal electroencephalographic rhythms from quiet wakefulness to light sleep in Alzheimer's disease patients with mild cognitive impairment 28
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study 24
Right posterior hypometabolism in Pisa syndrome of Parkinson's disease: A key to explain body schema perception deficit? 24
European consensus for the diagnosis of MCI and mild dementia: Preparatory phase 23
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 19
Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review 19
Relationship between default mode network and resting-state electroencephalographic alpha rhythms in cognitively unimpaired seniors and patients with dementia due to alzheimer’s disease 18
Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study 17
Longitudinal changes in [18F]FDG PET brain metabolism as a prognostic marker in autoimmune encephalitis 15
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders 15
Sex differences in brain atrophy in dementia with Lewy bodies 14
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer’s Disease 13
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration 11
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer’s Disease: A Review and Meta-Analysis 10
Resting state electroencephalographic alpha rhythms are sensitive to Alzheimer's disease mild cognitive impairment progression at a 6-month follow-up 10
Rituximab retreatment guided by CD27+ B-cell count vs. clinical relapse in anti-MAG polyneuropathy: a cost-effective approach with lower cumulative doses 8
Relationship between Posterior Resting-State Electroencephalographic Alpha Rhythms and Cerebrospinal Fluid Biomarkers of Neuropathology in Patients with Alzheimer’s Disease Mild Cognitive Impairment 8
Neuropsychological and clinical variables associated with cognitive trajectories in patients with Alzheimer's disease 7
Totale 7.131
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.003
article - articoli 27.394
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.366
Totale 57.763
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021264 0 0 0 0 0 55 44 31 30 55 21 28
2021/2022495 28 5 8 35 29 40 23 92 45 84 30 76
2022/2023561 40 60 8 51 70 70 7 49 85 22 84 15
2023/2024613 47 47 13 94 49 100 44 46 24 26 34 89
2024/20252.337 103 116 65 194 228 246 220 412 116 122 238 277
2025/20261.985 608 185 264 318 531 79 0 0 0 0 0 0
Totale 7.158